Since 2005, the DNDi office in the Democratic Republic of Congo (DRC) has provided essential logistical and financial support for the nifurtimox-eflornithine clinical trial (NECT), the fexinidazole trials, and the HAT Platform.

 


DNDi in Democratic Republic of Congo

Avenue Milambo, n°4
Quartier Socimat
Commune de la Gombe
Kinshasa
Democratic Republic of the Congo

Tel: +243 81 659 79 95